316 related articles for article (PubMed ID: 10647060)
41. Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes.
Kasim SE; Darga LL; Holden JH; Khilnani S; Patton S; Jen KL; Lucas CP
Int J Obes; 1991 Dec; 15(12):833-40. PubMed ID: 1794925
[TBL] [Abstract][Full Text] [Related]
42. Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase.
Liu MS; Jirik FR; LeBoeuf RC; Henderson H; Castellani LW; Lusis AJ; Ma Y; Forsythe IJ; Zhang H; Kirk E
J Biol Chem; 1994 Apr; 269(15):11417-24. PubMed ID: 8157673
[TBL] [Abstract][Full Text] [Related]
43. C57BL/KsJ-db/db-Apc mice exhibit an increased incidence of intestinal neoplasms.
Hata K; Kubota M; Shimizu M; Moriwaki H; Kuno T; Tanaka T; Hara A; Hirose Y
Int J Mol Sci; 2011; 12(11):8133-45. PubMed ID: 22174655
[TBL] [Abstract][Full Text] [Related]
44. Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
Blackett PR; Lee DM; Donaldson DL; Fesmire JD; Chan WY; Holcombe JH; Rennert OM
Pediatr Res; 1984 Sep; 18(9):864-70. PubMed ID: 6483510
[TBL] [Abstract][Full Text] [Related]
45. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
46. Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes.
Gumbiner B; Low CC; Reaven PD
Diabetes Care; 1998 Jan; 21(1):9-15. PubMed ID: 9538963
[TBL] [Abstract][Full Text] [Related]
47. Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus.
Rebuffé-Scrive M; Surwit R; Feinglos M; Kuhn C; Rodin J
Metabolism; 1993 Nov; 42(11):1405-9. PubMed ID: 8231834
[TBL] [Abstract][Full Text] [Related]
48. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
49. Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy.
Hammad SM; Powell-Braxton L; Otvos JD; Eldridge L; Won W; Lyons TJ
Metabolism; 2003 Jul; 52(7):916-21. PubMed ID: 12870170
[TBL] [Abstract][Full Text] [Related]
50. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
Taskinen MR; Packard CJ; Shepherd J
Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
[TBL] [Abstract][Full Text] [Related]
51. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
[TBL] [Abstract][Full Text] [Related]
52. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
53. Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin.
Billingham MS; Milles JJ; Bailey CJ; Hall RA
Metabolism; 1989 Sep; 38(9):850-7. PubMed ID: 2671598
[TBL] [Abstract][Full Text] [Related]
54. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
55. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G
Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191
[TBL] [Abstract][Full Text] [Related]
56. Differential expression of lipoprotein lipase gene in tissues of the rat model with visceral obesity and postprandial hyperlipidemia.
Hikita M; Bujo H; Yamazaki K; Taira K; Takahashi K; Kobayashi J; Saito Y
Biochem Biophys Res Commun; 2000 Oct; 277(2):423-9. PubMed ID: 11032739
[TBL] [Abstract][Full Text] [Related]
57. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels.
Rivellese AA; De Natale C; Di Marino L; Patti L; Iovine C; Coppola S; Del Prato S; Riccardi G; Annuzzi G
J Clin Endocrinol Metab; 2004 May; 89(5):2153-9. PubMed ID: 15126535
[TBL] [Abstract][Full Text] [Related]
58. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
[TBL] [Abstract][Full Text] [Related]
59. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
60. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
